David Suggitt is an accomplished executive director and global oncology marketing leader with extensive experience in the pharmaceutical industry. They have a proven track record in driving commercial success, developing innovative strategies, and leading high-performing teams in oncology and specialty therapeutic areas. Previously, Suggitt held significant roles at companies such as Merck, where they defined early commercialization strategies for oncology biosimilars and pioneered the development of groundbreaking therapies like HER3 directed Antibody Drug Conjugates. Currently, Suggitt is advancing their education through programs at prestigious institutions, including Duke University and UC Berkeley, focused on executive leadership and business technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices